跳至主要内容
临床试验/NL-OMON49683
NL-OMON49683已完成不适用

BACILLUS CALMETTE-GUÉRIN VACCINATION TO PREVENT SERIOUS RESPIRATORY TRACT INFECTION AND COVID-19 IN VULNERABLE ELDERLY -* AN ADAPTIVE RANDOMIZED CONTROLLED TRIAL - BCG-PRIME

niversitair Medisch Centrum Utrecht0 个研究点目标入组 6,112 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
6,112

研究概览

简要总结

Trial is onging in other countries

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Age *60 years
  • * Meeting at least one of the following criteria:
  • a) Having a chronic somatic disease*
  • b) Having undergone major surgery**
  • c) Planned to be discharged from the hospital or discharged from the hospital
  • less than 6 weeks ago; a hospital admission is defined as an overnight stay.
  • Departments of interest are those that in the opinion of the principle
  • investigator admit mostly vulnerable elderly and include but are not limited
  • to: cardiology, pulmonology, internal medicine, neurology.
  • d) Attending the thrombosis care service
  • * Written informed consent

排除标准

  • * Fever (>38 ºC) within the past 24 hours
  • * Suspicion of current active viral or bacterial infection; the requirement to
  • finish an antibiotic course upon discharge is not an exclusion criterion when
  • the infection is controlled in the opinion of the attending physician
  • * Vaccination with live vaccine in the past four weeks or planned vaccination
  • with live vaccine during the next four weeks
  • * Severely immunocompromised participants
  • * Known history of a positive Mantoux or active TB enHistory of documented

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验